Logo image of GSIW

GARDEN STAGE LTD (GSIW) Stock Fundamental Analysis

NASDAQ:GSIW - Nasdaq - KYG3730L1077 - Common Stock - Currency: USD

0.5299  -0.01 (-1.87%)

After market: 0.5201 -0.01 (-1.85%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GSIW. GSIW was compared to 225 industry peers in the Capital Markets industry. GSIW scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GSIW does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GSIW has reported negative net income.
In the past year GSIW has reported a negative cash flow from operations.
GSIW Yearly Net Income VS EBIT VS OCF VS FCFGSIW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M

1.2 Ratios

With a Return On Assets value of -27.67%, GSIW is not doing good in the industry: 97.26% of the companies in the same industry are doing better.
GSIW's Return On Equity of -49.43% is on the low side compared to the rest of the industry. GSIW is outperformed by 89.04% of its industry peers.
Industry RankSector Rank
ROA -27.67%
ROE -49.43%
ROIC N/A
ROA(3y)-11.42%
ROA(5y)N/A
ROE(3y)-150.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSIW Yearly ROA, ROE, ROICGSIW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 95.05%, GSIW belongs to the top of the industry, outperforming 94.06% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for GSIW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GSIW Yearly Profit, Operating, Gross MarginsGSIW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

GSIW has more shares outstanding than it did 1 year ago.
There is no outstanding debt for GSIW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GSIW Yearly Shares OutstandingGSIW Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
GSIW Yearly Total Debt VS Total AssetsGSIW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -0.15, we must say that GSIW is in the distress zone and has some risk of bankruptcy.
GSIW has a worse Altman-Z score (-0.15) than 80.82% of its industry peers.
GSIW has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.15
ROIC/WACCN/A
WACCN/A
GSIW Yearly LT Debt VS Equity VS FCFGSIW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 1.73 indicates that GSIW should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.73, GSIW is doing good in the industry, outperforming 65.75% of the companies in the same industry.
GSIW has a Quick Ratio of 1.73. This is a normal value and indicates that GSIW is financially healthy and should not expect problems in meeting its short term obligations.
GSIW's Quick ratio of 1.73 is fine compared to the rest of the industry. GSIW outperforms 66.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.73
GSIW Yearly Current Assets VS Current LiabilitesGSIW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for GSIW have decreased strongly by -3271.80% in the last year.
Looking at the last year, GSIW shows a very negative growth in Revenue. The Revenue has decreased by -56.80% in the last year.
EPS 1Y (TTM)-3271.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2299.86%
Revenue 1Y (TTM)-56.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSIW Yearly Revenue VS EstimatesGSIW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M
GSIW Yearly EPS VS EstimatesGSIW Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GSIW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSIW Price Earnings VS Forward Price EarningsGSIW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSIW Per share dataGSIW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GSIW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GARDEN STAGE LTD

NASDAQ:GSIW (2/26/2025, 5:44:19 PM)

After market: 0.5201 -0.01 (-1.85%)

0.5299

-0.01 (-1.87%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.37%
Inst Owner Change-40.14%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.28M
AnalystsN/A
Price TargetN/A
Short Float %1.95%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.88
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 0.9
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0.09
BVpS0.59
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.67%
ROE -49.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.05%
FCFM N/A
ROA(3y)-11.42%
ROA(5y)N/A
ROE(3y)-150.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.39%
Cap/Sales 0.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.73
Altman-Z -0.15
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)138.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.53%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3271.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2299.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-56.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2079.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-273.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-277.17%
OCF growth 3YN/A
OCF growth 5YN/A